NADMED forms global Scientific Advisory Board to advance redox diagnostics and precision medicine
The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways
The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways
The launch saw the presence of senior clinicians and leadership from the Manipal Hospitals network
The center brings together hands on technology demonstrations, application expertise, and commercial operations
The move opens Japan’s advanced life science market to Epigenica’s high-throughput epigenetic profiling kits
The two companies will collaborate to evaluate Hopewell’s ttLNPs for clinical applications
The partnership will focus on the ongoing SYNERGY-101 randomized Phase 2 trial for first-line
The clinical program has benefited from extensive European Union support, including the IMI2 TRIC-TB and UNITE4TB projects, as well as funding from the EDCTP2 bEto-TB project
Subscribe To Our Newsletter & Stay Updated